Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunter Biotech is a specialized biotechnology company and Contract Research Organization (CRO) based in Hangzhou, China, that focuses on zebrafish-based screening technologies. Established in 2010, the company provides a comprehensive suite of services for drug discovery, safety evaluation, and efficacy testing for the pharmaceutical, nutraceutical, and cosmetic industries. Their proprietary platform leverages the biological advantages of zebrafish to offer high-throughput, cost-effective alternatives to traditional mammalian animal testing. Hunter Biotech is recognized for its role in setting industrial standards for zebrafish testing in China and was the first in the country to achieve AAALAC accreditation for its zebrafish facilities. The company supports global clients in accelerating their R&D processes through innovative in vivo modeling.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Hunter Biotechnology.